All In MedTech

Device Trial Radar · NCT06835829

Comparing Advanced Hemostasis and Ultrasound-Guided Puncture to Conventional Approaches in Distal Radial Access

Comparing Advanced Hemostasis and Ultrasound-Guided Puncture to Conventional Approaches in Distal Radial Access: A Dual Randomized Pragmatic Trial

Last checked: Nov 19, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 480 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

480

Actual

Start

Dec 31, 2025

Primary completion

Jul 6, 2026

Study completion Jul 7, 2026

Sponsor

Sponsor type
Academic, hospital or other
First posted
Feb 19, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Meta-analysis results show that distal radial access (DRA) is associated with a significant reduction in the risk of radial artery occlusion compared to conventional transradial access (TRA). This is of paramount importance in an evolving interventional context where an increasing number of radial access procedures are being performed to address a growing number of independent health conditions. DRA is also associated with a lower rate of vascular access-related adverse events, establishing it as the safest vascular access ever. However, available data show that the success rate of DRA is lower than that of conventional TRA. Also, while the duration of hemostasis has been shown to be shorter, it has most likely not yet reached its full potential for shortening. Thus, the two extreme phases of DRA require important further evaluation. The CompAring uLtrasound-guided Puncture and advanced HemostAsis to cOnventional approaches in distal radial access: a dual randoMizEd praGmatic triAl (ALPHA\&OMEGA) trial will address this lack of knowledge by exploring whether a significantly shorter hemostasis duration can be achieved with DRA when using hemostasis enhancement and exploring whether ultrasound-guided puncture can increase the success rate of DRA.

Conditions

  • Coronary Catheterization

Interventions

  • Transradial potassium ferrate hemostatic patchDevice

    Use of a potassium ferrate hemostatic patch to enhance transradial access hemostasis

  • Distal radial potassium ferrate hemostatic patchDevice

    Use of a potassium ferrate hemostatic patch to enhance distal radial access hemostasis

  • Ultrasound-guidanceProcedure

    Ultrasound guidance for distal radial access

  • Conventional guidanceProcedure

    Conventional guidance for distal radial access

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Hemostasis duration.Time frame: From the time procedure ends until the time hemostasis ends, assessed up to 48 hours.
  2. Access successTime frame: Starts when the anesthesia needle contacts the skin and stops when the introducer sheath has been properly placed

Locations

6 sites in 2 countries. Site status is shown where the registry gives one.

  • Groupe Vivalia, Clinique Saint-Joseph

    Arlon, Belgium

  • CHU Charleroi-Chimay, Marie Curie Hospital

    Charleroi, Belgium

  • CHU Helora, Jolimont Hospital

    La Louvière, Belgium

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.